The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison-Reference-Cited by-同舟云学术

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

Published:2007-04 Issue:9570 Volume:369 Page:1347-1355
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sherman David G,Albers Gregory W,Bladin Christopher,Fieschi Cesare,Gabbai Alberto A,Kase Carlos S,O'Riordan William,Pineo Graham F

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century;Feigin;Lancet Neurol,2003

2. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Thom;Circulation,2006

3. Atherothrombosis: a major health burden;Leys;Cerebrovasc Dis,2001

4. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators;Johnston;Stroke,1998

5. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Geerts;Chest,2004

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels;Frontiers in Pharmacology;2024-07-12

2. Neurocritical Care for Patients With Ischemic Stroke;CONTINUUM: Lifelong Learning in Neurology;2024-06

3. Outcome of Pulmonary Embolism with and without Ischemic Stroke;Journal of Clinical Medicine;2024-05-07

4. Incidence of Symptomatic Venous Thromboembolisms in Stroke Patients;Journal of Intensive Care Medicine;2024-03-26

5. Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure;Journal of Health Economics and Outcomes Research;2024-02-20